# LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2026
Canonical URL: https://biopharmsignal.com/news/LFVN/lifevantage-announces-financial-results-for-the-third-quarter-of-fiscal-2026
Ticker: LFVN
Company: Lifevantage
Source: Lifevantage
Published: 2026-05-06 20:05 EST
Original Source URL: https://lifevantage.gcs-web.com
## Summary

SALT LAKE CITY, May 06, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its third fiscal quarter ended March 31, 2026.

## Article Body
SALT LAKE CITY, May 06, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its third fiscal quarter ended March 31, 2026.
## Recent Company News
- 2026-05-06 20:05 EST — [LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2026](https://biopharmsignal.com/news/LFVN/lifevantage-announces-financial-results-for-the-third-quarter-of-fiscal-2026) — Source: Lifevantage
- 2026-04-22 20:05 EST — [LifeVantage to Announce Third Quarter Fiscal Year 2026 Results on May 6, 2026](https://biopharmsignal.com/news/LFVN/lifevantage-to-announce-third-quarter-fiscal-year-2026-results-on-may-6-2026) — Source: Lifevantage
- 2026-04-21 12:00 EST — [LifeVantage Receives U.S. Patent for Healthy Glow Essentials Stack](https://biopharmsignal.com/news/LFVN/lifevantage-receives-u-s-patent-for-healthy-glow-essentials-stack) — Source: Lifevantage
- 2026-04-20 12:00 EST — [LifeVantage Inspires with ‘Breakthrough’ Announcements at 2026 Momentum Academy in Las Vegas](https://biopharmsignal.com/news/LFVN/lifevantage-inspires-with-breakthrough-announcements-at-2026-momentum-academy-in-las-vegas) — Source: Lifevantage
- 2026-04-16 21:15 EST — [LifeVantage Appointing Terrence Moorehead as Chief Executive Officer](https://biopharmsignal.com/news/LFVN/lifevantage-appointing-terrence-moorehead-as-chief-executive-officer) — Source: Lifevantage
## Related News
- 2026-07-21 20:15 EST — BFRG — [BullFrog AI to Participate in Water Tower Research Fireside Chat on Thursday, July 23, 2026](https://biopharmsignal.com/news/BFRG/bullfrog-ai-to-participate-in-water-tower-research-fireside-chat-on-thursday-jul-78357ce8)
- 2026-07-21 20:05 EST — CLPT — [ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026](https://biopharmsignal.com/news/CLPT/clearpoint-neuro-to-announce-second-quarter-2026-results-august-3-2026-6e4f3c05)
- 2026-07-21 20:05 EST — TCMD — [Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026](https://biopharmsignal.com/news/TCMD/tactile-medical-to-release-second-quarter-of-fiscal-year-2026-financial-results--798d4004)
- 2026-07-21 20:05 EST — PIII — [P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call](https://biopharmsignal.com/news/PIII/p3-health-partners-schedules-second-quarter-2026-earnings-release-and-conference-6c9bd8a7)
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)